With the clinical progress of immunotherapy in multiple solid tumors, anti-programmed cell death 1/ligand 1 (PD-1/PD-L1) checkpoint inhibitors have been utilized in the treatment of many types of cancer [8,9]. The gene discussed is CD274; the disease is cancer.